Further Information – Prana’s PBT2 Clinical Trials Cited as Most Advanced in Addressing Neurodegeneration from the Metal Equilibrium Perspective July 17, 2013
Alterity Therapeutics Announces Expanded ATH434 Phase 2 Clinical Development Program October 19, 2021November 9, 2021
